CFOO China Foods Holdings Ltd.
Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1310630 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-46.6%
TTM net income YoY33.6%
TTM EPS YoY0.0%
Revenue 3-yr CAGR-3.9%
Net income 3-yr CAGR—
Margins
Gross margin7.9%
Operating margin-173.9%
Net margin-173.8%
FCF margin—
EBITDA margin-170.1%
Returns
ROE—
ROA-114.1%
ROIC (approx.)—
Asset turnover0.66x
Leverage & solvency
Liabilities / assets756.1%
Debt / equity—
Current ratio0.11x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.09x
Accruals ratio10.3%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 | 2024Q32024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $2 | $253 | $88,788 | $96,828 | $142,214 | $41 | $183,319 | $22,403 |
| Cost of revenue | $0 | $24 | $83,281 | $87,958 | $126,654 | $16 | $150,937 | $21,088 |
| Gross profit | $2 | $229 | $5,507 | $8,870 | $15,560 | $25 | $32,382 | $1,315 |
| SG&A expense | $63,752 | $61,603 | $123,983 | $88,092 | $112,885 | $98,684 | $190,310 | $110,873 |
| Operating income | -$63,752 | -$61,598 | -$118,571 | -$79,256 | -$97,355 | -$103,741 | -$158,674 | -$110,669 |
| Pretax income | -$63,750 | -$61,597 | -$118,519 | -$79,246 | -$97,352 | -$103,555 | -$158,438 | -$110,630 |
| Income tax | $0 | — | — | — | $0 | — | $1 | $16,543 |
| Net income | -$63,750 | -$61,597 | -$118,519 | -$79,246 | -$97,352 | -$103,555 | -$158,439 | -$127,173 |
| EBITDA | -$62,000 | -$59,846 | -$116,816 | -$77,511 | -$95,613 | -$101,994 | -$157,100 | -$110,531 |
| EPS (basic) | 0.00 | 0.00 | — | 0.00 | 0.00 | -0.01 | — | -0.01 |
| EPS (diluted) | 0.00 | 0.00 | — | 0.00 | 0.00 | -0.01 | — | -0.01 |
| Weighted avg. shares (diluted) | 20.25M | 20.25M | — | 20.25M | 20.25M | 20.25M | — | 20.25M |
| Banking | ||||||||
| Net interest income | $2 | $1 | $29 | $10 | $2 | $4 | $18 | $24 |
| Balance sheet | ||||||||
| Cash & equivalents | $15,923 | $9,806 | $9,893 | $76,861 | $63,569 | $23,623 | $39,192 | $65,565 |
| Inventory | $40,407 | $39,737 | $39,255 | $45,634 | $98,238 | $78,502 | $54,943 | $70,530 |
| Current assets | $173,897 | $163,956 | $162,943 | $250,545 | $317,872 | $427,313 | $398,686 | $251,198 |
| PP&E, net | $24,708 | $26,217 | $27,860 | $29,346 | $30,858 | $32,557 | $34,264 | $16,859 |
| Intangibles | $1,465 | $1,562 | $1,662 | $1,751 | $1,856 | $1,949 | $2,055 | $2,259 |
| Total assets | $215,549 | $209,707 | $212,890 | $281,642 | $350,586 | $461,819 | $435,005 | $270,316 |
| Current liabilities | $1.63M | $1.54M | $1.48M | $1.43M | $1.41M | $1.42M | $1.29M | $966,078 |
| Total liabilities | $1.63M | $1.55M | $1.49M | $1.43M | $1.41M | $1.42M | $1.29M | $966,078 |
| Shareholders' equity | -$1.41M | -$1.34M | -$1.28M | -$1.15M | -$1.06M | -$954,953 | -$850,807 | -$695,762 |
| Shares outstanding | 20.25M | 20.25M | 20.25M | 20.25M | 20.25M | 20.25M | 20.25M | 20.25M |
| Cash flow statement | ||||||||
| Operating cash flow | -$93,772 | -$55,933 | -$133,340 | -$69,298 | -$85,743 | -$100,870 | -$152,134 | -$85,928 |
| Capital expenditure | — | — | — | — | — | — | $19,285 | $0 |
| Free cash flow | — | — | — | — | — | — | -$171,419 | -$85,928 |
| Investing cash flow | — | — | — | — | — | — | -$19,285 | $0 |
| Financing cash flow | $110,626 | $56,924 | $76,891 | $95,165 | $130,607 | $85,942 | $141,377 | $81,154 |
| Depreciation & amortization | $1,752 | $1,752 | $1,755 | $1,745 | $1,742 | $1,747 | $1,574 | $138 |
Free plan shows the latest 8 periods; Pro shows all 65 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.